SEC Form 4 · accession 0001437749-26-022009
Imunon, Inc. · IMNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas Vincent Faller
Officer — Chief Medical Officer
Period of report
Jun 25, 2026
Accepted (ET)
Jun 29, 2026 · 4:35 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000749647
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 25, 2026 | A | 21,896 | $1.72 | A | 21,896 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Stock granted in lieu of cash for 50% of 2025 annual cash bonus